Literature DB >> 18171917

Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD.

Jinfang Wu1, Md Riyaz Basha, Brian Brock, David P Cox, Fernando Cardozo-Pelaez, Christopher A McPherson, Jean Harry, Deborah C Rice, Bryan Maloney, Demao Chen, Debomoy K Lahiri, Nasser H Zawia.   

Abstract

The sporadic nature of Alzheimer's disease (AD) argues for an environmental link that may drive AD pathogenesis; however, the triggering factors and the period of their action are unknown. Recent studies in rodents have shown that exposure to lead (Pb) during brain development predetermined the expression and regulation of the amyloid precursor protein (APP) and its amyloidogenic beta-amyloid (Abeta) product in old age. Here, we report that the expression of AD-related genes [APP, BACE1 (beta-site APP cleaving enzyme 1)] as well as their transcriptional regulator (Sp1) were elevated in aged (23-year-old) monkeys exposed to Pb as infants. Furthermore, developmental exposure to Pb altered the levels, characteristics, and intracellular distribution of Abeta staining and amyloid plaques in the frontal association cortex. These latent effects were accompanied by a decrease in DNA methyltransferase activity and higher levels of oxidative damage to DNA, indicating that epigenetic imprinting in early life influenced the expression of AD-related genes and promoted DNA damage and pathogenesis. These data suggest that AD pathogenesis is influenced by early life exposures and argue for both an environmental trigger and a developmental origin of AD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18171917      PMCID: PMC2486412          DOI: 10.1523/JNEUROSCI.4405-07.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  42 in total

1.  Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report.

Authors:  Hamid Mostafavi Abdolmaleky; Kuang-hung Cheng; Andrea Russo; Cassandra L Smith; Stephen V Faraone; Marsha Wilcox; Rahim Shafa; Stephen J Glatt; Giang Nguyen; Joe F Ponte; Sam Thiagalingam; Ming T Tsuang
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-04-05       Impact factor: 3.568

2.  Neonatal infection induces memory impairments following an immune challenge in adulthood.

Authors:  Staci D Bilbo; Lindsay H Levkoff; John H Mahoney; Linda R Watkins; Jerry W Rudy; Steven F Maier
Journal:  Behav Neurosci       Date:  2005-02       Impact factor: 1.912

3.  Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model.

Authors:  Oded Singer; Robert A Marr; Edward Rockenstein; Leslie Crews; Nicole G Coufal; Fred H Gage; Inder M Verma; Eliezer Masliah
Journal:  Nat Neurosci       Date:  2005-08-28       Impact factor: 24.884

4.  Reduction with age in methylcytosine in the promoter region -224 approximately -101 of the amyloid precursor protein gene in autopsy human cortex.

Authors:  H Tohgi; K Utsugisawa; Y Nagane; M Yoshimura; Y Genda; M Ukitsu
Journal:  Brain Res Mol Brain Res       Date:  1999-07-05

5.  The fetal basis of amyloidogenesis: exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain.

Authors:  M Riyaz Basha; Wei Wei; Saleh A Bakheet; Nathalie Benitez; Hasan K Siddiqi; Yuan-Wen Ge; Debomoy K Lahiri; Nasser H Zawia
Journal:  J Neurosci       Date:  2005-01-26       Impact factor: 6.167

6.  Obstetric complications and the risk of schizophrenia: a longitudinal study of a national birth cohort.

Authors:  C Dalman; P Allebeck; J Cullberg; C Grunewald; M Köster
Journal:  Arch Gen Psychiatry       Date:  1999-03

7.  A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A.

Authors:  Yong-Hui Jiang; Trilochan Sahoo; Ron C Michaelis; Dani Bercovich; Jan Bressler; Catherine D Kashork; Qian Liu; Lisa G Shaffer; Richard J Schroer; David W Stockton; Richard S Spielman; Roger E Stevenson; Arthur L Beaudet
Journal:  Am J Med Genet A       Date:  2004-11-15       Impact factor: 2.802

Review 8.  Free radical damage, iron, and Alzheimer's disease.

Authors:  M A Smith; G Perry
Journal:  J Neurol Sci       Date:  1995-12       Impact factor: 3.181

Review 9.  Environmental risk factors and the developmental basis for Alzheimer's disease.

Authors:  Nasser H Zawia; M Riyaz Basha
Journal:  Rev Neurosci       Date:  2005       Impact factor: 4.353

10.  The upstream promoter of the beta-amyloid precursor protein gene (APP) shows differential patterns of methylation in human brain.

Authors:  E I Rogaev; W J Lukiw; O Lavrushina; E A Rogaeva; P H St George-Hyslop
Journal:  Genomics       Date:  1994-07-15       Impact factor: 5.736

View more
  140 in total

1.  Formaldehyde, Epigenetics, and Alzheimer's Disease.

Authors:  Fei Wang; Danqi Chen; Peipei Wu; Catherine Klein; Chunyuan Jin
Journal:  Chem Res Toxicol       Date:  2019-04-19       Impact factor: 3.739

Review 2.  Alzheimer's disease and environmental exposure to lead: the epidemiologic evidence and potential role of epigenetics.

Authors:  Kelly M Bakulski; Laura S Rozek; Dana C Dolinoy; Henry L Paulson; Howard Hu
Journal:  Curr Alzheimer Res       Date:  2012-06       Impact factor: 3.498

3.  Evidence for altered hippocampal volume and brain metabolites in workers occupationally exposed to lead: a study by magnetic resonance imaging and (1)H magnetic resonance spectroscopy.

Authors:  Yue-Ming Jiang; Li-Ling Long; Xia-Yan Zhu; Hong Zheng; Xue Fu; Shi-Yan Ou; Dong-Lu Wei; Hai-Lin Zhou; Wei Zheng
Journal:  Toxicol Lett       Date:  2008-07-23       Impact factor: 4.372

4.  Histone acetylation maps in aged mice developmentally exposed to lead: epigenetic drift and Alzheimer-related genes.

Authors:  Aseel Eid; Syed Waseem Bihaqi; Christopher Hemme; John M Gaspar; Ronald P Hart; Nasser H Zawia
Journal:  Epigenomics       Date:  2018-05-03       Impact factor: 4.778

Review 5.  Pharmacology of epigenetics in brain disorders.

Authors:  Pritika Narayan; Mike Dragunow
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

Review 6.  Early-life events may trigger biochemical pathways for Alzheimer's disease: the "LEARn" model.

Authors:  Debomoy K Lahiri; Nasser H Zawia; Nigel H Greig; Kumar Sambamurti; Bryan Maloney
Journal:  Biogerontology       Date:  2008-07-31       Impact factor: 4.277

Review 7.  Evolution in health and medicine Sackler colloquium: Evolution of the human lifespan and diseases of aging: roles of infection, inflammation, and nutrition.

Authors:  Caleb E Finch
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

8.  Gene × environment interaction by a longitudinal epigenome-wide association study (LEWAS) overcomes limitations of genome-wide association study (GWAS).

Authors:  Debomoy K Lahiri; Bryan Maloney
Journal:  Epigenomics       Date:  2012-12       Impact factor: 4.778

Review 9.  Epigenetics of early-life lead exposure and effects on brain development.

Authors:  Marie-Claude Senut; Pablo Cingolani; Arko Sen; Adele Kruger; Asra Shaik; Helmut Hirsch; Steven T Suhr; Douglas Ruden
Journal:  Epigenomics       Date:  2012-12       Impact factor: 4.778

10.  Tolfenamic acid downregulates BACE1 and protects against lead-induced upregulation of Alzheimer's disease related biomarkers.

Authors:  Lina Adwan; Gehad M Subaiea; Nasser H Zawia
Journal:  Neuropharmacology       Date:  2014-01-21       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.